Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.

Poole E, Groves I, MacDonald A, Pang Y, Alcami A, Sinclair J.

J Virol. 2009 Apr;83(8):3581-90. doi: 10.1128/JVI.02072-08. Epub 2009 Jan 28.

2.

The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism.

Poole E, King CA, Sinclair JH, Alcami A.

EMBO J. 2006 Sep 20;25(18):4390-9. Epub 2006 Aug 24.

3.

NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86.

Poole E, Atkins E, Nakayama T, Yoshie O, Groves I, Alcami A, Sinclair J.

J Virol. 2008 May;82(9):4250-6. doi: 10.1128/JVI.02156-07. Epub 2008 Feb 20.

5.

The human cytomegalovirus UL26 protein antagonizes NF-κB activation.

Mathers C, Schafer X, Martínez-Sobrido L, Munger J.

J Virol. 2014 Dec;88(24):14289-300. doi: 10.1128/JVI.02552-14. Epub 2014 Oct 1.

6.

Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling.

Montag C, Wagner J, Gruska I, Hagemeier C.

J Virol. 2006 Dec;80(23):11686-98. Epub 2006 Sep 27.

7.

Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus.

Benedict CA, Butrovich KD, Lurain NS, Corbeil J, Rooney I, Schneider P, Tschopp J, Ware CF.

J Immunol. 1999 Jun 15;162(12):6967-70.

8.

Biphasic regulation of A20 gene expression during human cytomegalovirus infection.

Gu SY, Kim YE, Kwon KM, Han TH, Ahn JH.

Virol J. 2014 Jul 8;11:124. doi: 10.1186/1743-422X-11-124.

9.

The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner.

Poole E, Walther A, Raven K, Benedict CA, Mason GM, Sinclair J.

J Virol. 2013 Apr;87(8):4261-71. doi: 10.1128/JVI.03497-12. Epub 2013 Jan 30.

10.

MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.

Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ, Mansell A.

J Biol Chem. 2009 Sep 4;284(36):24192-203. doi: 10.1074/jbc.M109.023044. Epub 2009 Jul 10.

11.

Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.

Jiang Z, Mak TW, Sen G, Li X.

Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3533-8. Epub 2004 Feb 24.

13.
14.

Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.

Prösch S, Priemer C, Höflich C, Liebenthaf C, Babel N, Krüger DH, Volk HD.

Antivir Ther. 2003 Dec;8(6):555-67.

PMID:
14760889
15.

NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?

Prösch S, Wuttke R, Krüger DH, Volk HD.

Biol Chem. 2002 Oct;383(10):1601-9.

PMID:
12452437
16.

Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.

DeMeritt IB, Podduturi JP, Tilley AM, Nogalski MT, Yurochko AD.

Virology. 2006 Mar 1;346(1):15-31. Epub 2005 Nov 21.

17.

TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.

Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y, Inoue J.

PLoS One. 2009 May 25;4(5):e5674. doi: 10.1371/journal.pone.0005674.

18.

Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells.

Caposio P, Musso T, Luganini A, Inoue H, Gariglio M, Landolfo S, Gribaudo G.

Antiviral Res. 2007 Mar;73(3):175-84. Epub 2006 Oct 23.

PMID:
17070604
20.

NF-kappaB activation can mediate inhibition of human cytomegalovirus replication.

Eickhoff JE, Cotten M.

J Gen Virol. 2005 Feb;86(Pt 2):285-95.

PMID:
15659747

Supplemental Content

Support Center